Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from CLEO Diagnostics Ltd ( (AU:COV) ).
Cleo Diagnostics Ltd has announced that its 2025 Annual General Meeting (AGM) will be held on November 24, 2025. The company also informed stakeholders that the deadline for director nominations is set for October 6, 2025. This announcement is significant as it sets the stage for potential changes in the company’s leadership and strategic direction, which could impact its market positioning and stakeholder interests.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the healthcare industry, focusing on diagnostic solutions. The company is listed on the Australian Securities Exchange (ASX) under the ticker COV and is based in Melbourne, Australia.
Average Trading Volume: 82,561
Technical Sentiment Signal: Hold
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.